S1 Ep210: Elevating Precision Medicine Across Different Oncologic Populations

About this episode

The episode discusses advancements in precision medicine and targeted therapies presented at the Miami Precision Medicine Conference.

At the 3rd Biennial Miami Precision Medicine Conference, CancerNetwork® spoke with a variety of researchers and clinicians who presented on different topics regarding the use of targeted therapies across several cancer types. Faculty from the University of Miami Sylvester Comprehensive Cancer Center shared key advances and ongoing initiatives across pancreatic cancer, sarcomas, genitourinary malignancies, and other diseases. First, Jashodeep Datta, MD, an associate professor of surgery, a co-leader of the Gastrointestinal Site Disease Group, an associate director of Translational Research, and Sylvester Pancreatic Cancer Research Institute DiMare Family Endowed Chair in Immunotherapy, discussed his presentation on overcoming a historical “moratorium” associated with immunotherapy in pancreatic cancer. Based on recent data, he noted that current goals include analyzing distinct subpopulations of patients who respond to immunotherapy and understanding the biology of why they respond to inform the design of novel therapeutic approaches. Looking towards the future, Datta described how mRNA vaccines may play a larger role in advancing personalized patient care. Next, Steven Bialick…

People in this episode

Guests: Jashodeep Datta, MD, Steven Bialick, DO

Topics covered

• precision medicine
• targeted therapies
• immunotherapy
• pancreatic cancer
• sarcomas
• genitourinary malignancies

Keywords

• precision medicine
• immunotherapy
• pancreatic cancer
• sarcomas
• targeted therapies
• mRNA vaccines
• microsatellite instability

Mentioned in this episode

Organizations: University of Miami Sylvester Comprehensive Cancer Center, CancerNetwork, Sylvester Pancreatic Cancer Research Institute, Gastrointestinal Site Disease Group, DiMare Family Endowed Chair in Immunotherapy

More episodes of Oncology On The Go

• S1 Ep218: Unraveling Key Hematologic Oncology Developments at ASCO 2026 · June 8, 2026 · 24 min
• S1 Ep217: Integrating Exercise and Lifestyle Intervention Into Oncologic Therapy · June 1, 2026 · 29 min
• S1 Ep216: How the Landscape of GI Oncology is Evolving | A 2026 ASCO Preview · May 28, 2026 · 29 min
• S1 Ep215: Navigating The Dynamic Landscape of Stem Cell Transplantation · May 25, 2026 · 11 min
• S1 Ep214: Are Zedoresertib and Lunresertib an Efficacious Combo Across Solid Tumors? · May 18, 2026 · 13 min
• S1 Ep213: What Does the Future Hold for Immune Effector Cell Therapies? · May 11, 2026 · 12 min